Locations:

News & Insight

October 14, 2019/Cancer/News & Insight

Jame Abraham, MD, FACP, Named Chair of Hematology/Medical Oncology

Renowned breast cancer researcher and editor to lead department

July 31, 2019/Bioethics

Dear Clinical Trial Participant: Thanks for Your Help. Now Pay Up.

Drug makers shouldn’t penalize patients who helped them profit, an oncologist argues

July 24, 2019/Cancer/News & Insight

On Opioids and Oncology

Addressing a patient’s addiction fears versus the need for pain relief

June 17, 2019/Cancer/News & Insight

Genetic Models for Renal Cell Carcinoma Risk Stratification: Current Status and Future Prospects

Better assessing individual risk of recurrence

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 3, 2019/Cancer/News & Insight

Impact of Exercise and Demographics in Breast Cancer Survivors Over Age 65

Can exercise intervention reduce racial and socioeconomic disparities in health outcomes?

March 22, 2019/Cancer/News & Insight

Time-to-Treat, Two Years Later

Our Cancer Center Chair reflects on progress and potential

March 21, 2019/Cancer/News & Insight

Understanding Rheumatologic Immune-Related Adverse Events in Genitourinary Cancers

Cases of myalgia and arthralgia after CPI

February 20, 2019/Cancer/News & Insight

Expertise in Rare Cancers and Blood Disorders

From amyloidosis to small cell bladder cancer

February 11, 2019/Cancer/News & Insight

Risk of Epstein-Barr-Associated Post-Transplant Lymphoproliferative Disorders Low in Solid Organ Transplant Patients

Liver and intestine recipients at greater risk

February 6, 2019/Cancer/News & Insight

Chipping Away at the Mystery of Clonal Hematopoiesis of Indeterminate Potential (CHIP)

CHIP clinic in the works

BackPage 8 of 18Next